Parkinson's Puzzle: When Genetics Don't Add Up
"Exploring the unexpected twists in a family's PARK2 gene mutations and what it means for understanding early-onset Parkinson's disease."
Parkinson's disease, a condition often associated with older adults, can sometimes strike much earlier in life. Early-onset Parkinson's disease (EOPD) typically before age 50, presents unique challenges for diagnosis and treatment. While genetics plays a significant role, the story is rarely straightforward. One gene in particular, PARK2, has been strongly linked to EOPD. When both copies of this gene are mutated, it often leads to the disease. But what happens when the genetic picture is less clear? What if someone has only one mutated copy, or even multiple copies? Can mutations hide in plain sight, or are the effects modified by hidden genetic factors?
Biallelic mutations in the PARK2 gene, which encodes Parkin, are the most common cause of autosomal recessive, early onset Parkinson disease (EOPD), with frequency inversely correlated with age at onset and complete penetrance. Single heterozygous PARK2 mutations are occasionally detected in patients with PD and in healthy individuals and are considered minor susceptibility factors toward the risk of sporadic later onset PD.
A recent study from Italy has illuminated these complexities, describing a family with a perplexing inheritance pattern of PARK2 mutations. This case challenges our traditional understanding of how these mutations cause Parkinson's disease and highlights the need to look beyond simple genetic explanations.
A Growing Genetic Burden
Parkinson's disease accounts for a significant burden on modern society, with cases increasing rapidly. Variants in genes including GBA have been linked to disease risk, while SNCA, LRRK2, and VPS35 are associated with autosomal dominant Parkinson's disease and PRKN, PINK1, and DJ-1 with autosomal recessive forms. Genetic variants provide one way to subdivide Parkinson's disease, and the Global Parkinson’s Genetics Program was created in part to address regional differences in genetic studies.
What Genetic Testing Can—and Cannot—Explain
Parkin mutations responsible for PARK2 and LRRK2 mutations are described as among the most common genetic causes of Parkinson's disease. PARK2 mutations are a common cause of autosomal recessive early-onset Parkinson's disease, and loss-of-function effects can directly link parkin mutations to neuronal cell loss. However, the genetic landscape also includes rare high-penetrance variants, risk-factor variants, and common low-penetrance variants, meaning that genetic findings do not explain all sporadic disease in the same way.
From PARK2 to a Complex Architecture
The identification of the parkin gene, PARK2, in 1998 marked a pivotal moment in Parkinson's disease research and established a genetic basis for a significant subset of early-onset cases. Later work showed that Parkinson's disease involves both rare and common genetic variants that contribute to risk, onset, and progression. Mutations in more than 20 genes have been associated with the disease, many of them highly penetrant and linked to early-onset or atypical symptoms.
The Curious Case of the PARK2 Mutation
The Italian study focused on a family with a history of early-onset Parkinson's disease. The index patient, a 41-year-old male, began experiencing motor symptoms such as slowness and rigidity at age 36. A dopamine transporter (DAT) scan confirmed reduced dopaminergic activity in his brain, and he responded well to medication. Genetic testing revealed a heterozygous duplication of exons 2 and 3 in the PARK2 gene.
- The patient's mother and brother did not carry any PARK2 exon duplication, suggesting that the proband was heterozygous for a duplication of Exons 2 and 3 in cis on the same allele.
- They examined the patient's paternal aunt and uncovered an even more startling finding: she was homozygous for the same duplication, carrying four copies of exons 2 and 3.
Expanding the Genetic Map
A 2025 updated MDSGene review identifies pathogenic LRRK2 variants as one of the most commonly identifiable monogenic causes of Parkinson's disease. Recent research also emphasizes genomic diversity, including admixed and historically underrepresented populations in Parkinson's genetic studies. Knowledge has grown from the discovery of the first monogenic form caused by an alpha-synuclein mutation to the identification of multiple causative genes and associated loci.
The Representation Gap
Next-generation sequencing has identified pathogenic variants in Parkinson's disease and related disorders. However, data from admixed populations such as Brazilians remain limited. This limitation means that genetic findings developed from better-studied populations may not fully represent the disease patterns or variants present in underrepresented groups.
Parkin Syndrome and Typical Parkinson's
Parkin mutations in the PARK2 gene are the most common cause of autosomal recessive early-onset Parkinson's disease, while most Parkinson's disease cases are sporadic. Parkin syndrome is a hereditary form caused by PRKN mutations, historically called PARK2, and accounts for roughly half of autosomal recessive early-onset parkinsonism cases according to the cited source. The condition was first linked to a specific gene in 1998 by researchers in Japan, who named the protein product Parkin.
Decoding the Genetic Puzzle
The case of this Italian family highlights the complex interplay between genetics and Parkinson's disease. While mutations in genes like PARK2 can increase the risk of developing the condition, they do not guarantee it. Other genetic factors, environmental influences, and even lifestyle choices can modify the effects of these mutations, potentially delaying or preventing the onset of symptoms. The study underscores the need for caution when interpreting genetic test results and emphasizes the importance of a holistic approach to understanding Parkinson's disease. Further research is needed to identify the factors that can modify the effects of PARK2 mutations and to develop personalized strategies for prevention and treatment. The search for answers continues, with each new discovery bringing us closer to unraveling the mysteries of this debilitating disease.
Beyond Inherited Mutations
Germline mutations in PARK2 are a well-known cause of Parkinson's disease. Research has also reported somatic mutations and intragenic deletions in PARK2. This distinction broadens the genetic puzzle beyond variants inherited through the germline and raises the importance of examining genetic changes that arise within cells.
Parkin and Mitochondrial Health
The parkin protein, encoded by PARK2, is described as vital for mitochondrial homeostasis. Although parkin has been implicated in Parkinson's disease, the mechanisms connecting its dysfunction to disease remain unclear. A 2019 study used mass spectrometry-based proteomics to investigate mitochondrial-proteome changes in human isogenic induced pluripotent stem cell-derived neurons.